These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

106 related items for PubMed ID: 6314955

  • 1. Epstein-Barr virus antibody titers in cancer of the head and neck.
    Callaghan DJ, Conner BR, Strauss M.
    Arch Otolaryngol; 1983 Dec; 109(12):781-4. PubMed ID: 6314955
    [Abstract] [Full Text] [Related]

  • 2. Significance of specific Epstein-Barr virus IgA and elevated IgG antibodies to viral capsid antigens in nasopharyngeal carcinoma patients.
    Hadar T, Rahima M, Kahan E, Sidi J, Rakowsky E, Sarov B, Sarov I.
    J Med Virol; 1986 Dec; 20(4):329-39. PubMed ID: 3025351
    [Abstract] [Full Text] [Related]

  • 3. Epstein-Barr virus-specific serodiagnostic tests in carcinomas of the head and neck.
    Ringborg U, Henle W, Henle G, Ingimarsson S, Klein G, Silfversward C, Strander H.
    Cancer; 1983 Oct 01; 52(7):1237-43. PubMed ID: 6309355
    [Abstract] [Full Text] [Related]

  • 4. Prognostic value of anti-Epstein-Barr virus antibodies in nasopharyngeal carcinoma (NPC).
    Liu MT, Yeh CY.
    Radiat Med; 1998 Oct 01; 16(2):113-7. PubMed ID: 9650898
    [Abstract] [Full Text] [Related]

  • 5. Significance of plasma IgA and IgG antibodies to Epstein-Barr virus early and viral capsid antigens in Thai nasopharyngeal carcinoma.
    Tiwawech D, Srivatanakul P, Karaluk A, Ishida T.
    Asian Pac J Cancer Prev; 2003 Oct 01; 4(2):113-8. PubMed ID: 12875623
    [Abstract] [Full Text] [Related]

  • 6. Epstein-Barr virus-specific IgA serum antibodies as an outstanding feature of nasopharyngeal carcinoma.
    Henle G, Henle W.
    Int J Cancer; 1976 Jan 15; 17(1):1-7. PubMed ID: 175020
    [Abstract] [Full Text] [Related]

  • 7. Increased incidence of IgA antibodies to the Epstein-Barr virus-associated viral capsid antigen and early antigens in patients with chronic lymphocytic leukemia.
    Dölken G, Bross KJ, Hecht T, Brugger W, Löhr GW, Hirsch FW.
    Int J Cancer; 1986 Jul 15; 38(1):55-9. PubMed ID: 3013785
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Titers of Epstein-Barr virus-related antibodies in nasopharyngeal carcinoma in Japan.
    Tamada A, Makimoto K, Yamabe H, Imai J, Hinuma Y, Oyagi A, Araki T.
    Cancer; 1984 Feb 01; 53(3):430-40. PubMed ID: 6318948
    [Abstract] [Full Text] [Related]

  • 10. Prognostic implication of pretreatment titer of serum immunoglobulin A against Epstein-Barr virus capsid antigen in nasopharyngeal carcinoma patients in Sihui, Guangdong.
    Ling W, Cao SM, Huang QH, Li YH, Deng MQ.
    Ai Zheng; 2009 Jan 01; 28(1):57-9. PubMed ID: 19448418
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. The reliability of IgA antibody to Epstein-Barr virus (EBV) capsid antigen as a test for the diagnosis of nasopharyngeal carcinoma (NPC).
    Levine PH, Pearson GR, Armstrong M, Bengali Z, Berenberg J, Easton J, Goepfert H, Henle G, Henle W, Heffner D, Huang A, Hyams VJ, Lanier A, Neel HB, Pilch B, Pointek N, Taylor W, Terebelo H, Weiland L.
    Cancer Detect Prev; 1981 Jan 01; 4(1-4):307-12. PubMed ID: 6299561
    [Abstract] [Full Text] [Related]

  • 16. Serologic diagnosis of nasopharyngeal carcinoma. A double-blind study of four EB virus antibodies with evaluation by sequential discrimination.
    Cai WM, Li YW, Wu B, Liu YY, Hu YH, Gu XZ, Liu HY, Wang GD.
    Int J Radiat Oncol Biol Phys; 1983 Dec 01; 9(12):1763-8. PubMed ID: 6319338
    [Abstract] [Full Text] [Related]

  • 17. Single-assay combination of Epstein-Barr Virus (EBV) EBNA1- and viral capsid antigen-p18-derived synthetic peptides for measuring anti-EBV immunoglobulin G (IgG) and IgA antibody levels in sera from nasopharyngeal carcinoma patients: options for field screening.
    Fachiroh J, Paramita DK, Hariwiyanto B, Harijadi A, Dahlia HL, Indrasari SR, Kusumo H, Zeng YS, Schouten T, Mubarika S, Middeldorp JM.
    J Clin Microbiol; 2006 Apr 01; 44(4):1459-67. PubMed ID: 16597877
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.